BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 26189249)

  • 21. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
    Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
    Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
    Catenacci DV; Cervantes G; Yala S; Nelson EA; El-Hashani E; Kanteti R; El Dinali M; Hasina R; Brägelmann J; Seiwert T; Sanicola M; Henderson L; Grushko TA; Olopade O; Karrison T; Bang YJ; Kim WH; Tretiakova M; Vokes E; Frank DA; Kindler HL; Huet H; Salgia R
    Cancer Biol Ther; 2011 Jul; 12(1):9-46. PubMed ID: 21543897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
    Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic value of tgfb1 protein in endometrioid adenocarcinoma.
    Soufla G; Sifakis S; Porichis F; Spandidos DA
    Eur J Clin Invest; 2013 Jan; 43(1):79-90. PubMed ID: 23176363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.
    Zhuang XP; Jin WW; Teng XD; Yuan ZZ; Lin QQ; Xu ST
    Eur J Gynaecol Oncol; 2015; 36(3):255-9. PubMed ID: 26189249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy.
    Yao HP; Tong XM; Hudson R; Wang MH
    J Exp Clin Cancer Res; 2020 Sep; 39(1):198. PubMed ID: 32962738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.
    Kim HG; Kim H; Yeo MK; Won KY; Kim YS; Han GH; Kim HS; Na K
    Cancer Genomics Proteomics; 2022; 19(4):526-539. PubMed ID: 35732320
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.